Detalhe da pesquisa
1.
Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.
Acta Derm Venereol
; 93(3): 346-9, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23073990